In a landmark announcement, the NHS has introduced a beacon of hope for individuals susceptible to type 1 diabetes.
A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by ...
A new first-of-its-kind treatment which has been found to delay the onset of type 1 diabetes has been approved for use in the ...
Every individual living with type 1 diabetes understands the discipline the condition demands. Even minor deviations can ...
Lehigh Valley Hospital–Cedar Crest and LVH–Muhlenberg have been recognized for their performance in caring for patients with ...
If you have diabetes, it’s essential that you pay special attention to the health of your feet. Diabetes can increase your risk of foot problems because high blood sugar can contribute to nerve damage ...
A university has been awarded £1.3m to try and improve diabetes care for young adults. Researchers at Northumbria University ...
Daily Mail on MSN
'First of its kind' drug that delays type 1 diabetes by up to three years is approved by the NHS
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the ...
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, which the charity Diabetes UK said ...
The immunotherpay can give children and adults three extra years before they need to use insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results